TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Modalis Therapeutics Corporation ( (JP:4883) ) has issued an announcement.
Modalis Therapeutics Corporation announced a proposal to amend its Articles of Incorporation to increase the total number of authorized shares from 100,400,000 to 277,000,000. This strategic move aims to provide the company with more flexibility in capital raising and enhance its capital policy, potentially impacting its growth and market strategy.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is listed on the Tokyo Stock Exchange and specializes in developing therapeutic solutions. The company focuses on innovative gene therapies and is positioned in the biotechnology sector.
YTD Price Performance: -1.96%
Average Trading Volume: 6,590,179
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen7.42B
For detailed information about 4883 stock, go to TipRanks’ Stock Analysis page.